Updated:
Ventura BioMed Investors
Ventura Biomed Investors is led by serial entrepreneurs with experience in the biotech and pharmaceutical industry. The firm helps shape the long-term...
Ventura BioMed Investors
Ventura Biomed Investors is led by serial entrepreneurs with experience in the biotech and pharmaceutical industry. The firm helps shape the long-term development of its portfolio companies and provides access to a broad investor and business network. It typically invests EUR 1–5 million per company, always in consortia with other funds and within Europe, focusing on early-stage life science companies developing pioneering technologies and innovative therapies.
General information
Firm type
Private Equity
Location
Region
Europe
Country
Germany
City
Munich
Corporate office
Munich, Germany
Principals
Dr. Andreas Jenne
Dr. Kurt Rudolf Schwarz
Sector focus
Frequently asked questions
How does Ventura BioMed Investors source deals?
The firm's Munich headquarters positions it within the DACH region's leading life-sciences cluster, providing access to spin-outs from institutions including the Max Planck Society and Technical University of Munich. Its deal flow draws on academic collaborations, translational-research networks, and direct relationships with scientific founders across Germany and the broader European Union.
Does Ventura BioMed Investors invest globally or remain Europe-focused?
The firm maintains a primary geographic emphasis on the DACH region — Germany, Austria, and Switzerland — while selectively reviewing opportunities in other European Union markets. No investments outside Europe are publicly associated with the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: